診断用心電計（ECG）市場 : 2028年までの世界予測

Report Overview

The global diagnostic electrocardiogram (ECG) market is projected to reach USD 11.3 billion by 2028 from USD 8.1 billion in 2023, at a CAGR of 6.9% during the forecast period. The rising prevalence of cardiovascular and lifestyle diseases, growing demand for early cardiac diseases diagnosis , technological advancements in wearable ECG devices, increasing proportion of aging population, increasing healthcare infrastructure and growing geographical presence of diagnostic ECG manufacturers globally.

“Resting ECG Devices segment to dominate diagnostic electrocardiogram (ECG) market during the forecast period.”
Based on product type, the diagnostic ECG market is segmented into devices and software & Services . The devices segment is categorized into resting ECG devices, stress ECG devices, Holter monitors, event monitors, implantable loop recorders, mobile cardiac telemetry devices, and smart ECG devices. The resting ECG devices segment captured the largest share of diagnostic ECG market in 2022 attributed to the increasing availability of cost effective resting ECG devices and wider adoption of resting ECG devices in hospital settings.

“12 lead , by lead type , accounted for the largest market share of global diagnostic electrocardiogram (ECG) market in 2022.”
Based on lead type, the diagnostic electrocardiogram (ECG) market is segmented into patch type 12-lead, 5-lead, 3-lead, 6-lead, single lead, and other lead types (such as 13 lead, 18- lead). In 2022, the 12-lead segment accounted for the largest share of the diagnostic ECG market. This is mainly attributed to higher clarity obtained by using a larger number of leads; 12-lead ECG devices provide a highly detailed outlook, making it easier to interpret cardiac electrical activity.

“The hospitals, clinics, and cardiac centers to dominate the global electrocardiogram ECG market in 2022.”
Based on end user, the diagnostic electrocardiogram (ECG) market is segmented into hospitals, clinics, and Cardiac Centers, ambulatory surgical centers, and other end users. The hospitals, clinics, and Cardiac Centers segment accounted for the largest share of the global market in 2022 attributed to the increasing prevalence of cardiovascular diseases, establishment of cardiac centers, and increasing government funding to expand and improve the services offered by hospitals.

“The APAC market, by region, to register highest growth rate in the forecast period.”
On the basis of region, the diagnostic electrocardiogram (ECG) market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the largest share and expects to dominate the diagnostic ECG market. The Asia-Pacific market is likely witnessing significant growth owing to increase in disposable income and increase in cardiovascular patient pool. Rising penetration of advanced diagnostic ECG in hospitals, and growing healthcare expenditure

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, MEA- 3%

The prominent players in the diagnostic electrocardiogram (ECG) market are GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Hill-Rom Holdings, Inc. (Baxter International Inc.) (US), Mindray Medical International Limited (China), SCHILLER AG (Switzerland), Bittium Corporation (Finland), Fukuda Denshi Co., Ltd. (Japan), BPL Medical Technologies Pvt. Ltd. (India), among others.

Research Coverage
This report studies the diagnostic electrocardiogram (ECG) market based on product type, lead type, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:
• Analysis of key drivers ( rising prevalence of cardiovascular diseases, increasing geriatric population growing demand for remote monitoring, technological advancements in wireless ECG devices ) restraints (stringent regulatory approvals delaying the approval of diagnosis ECG devices ), opportunities (rising healthcare expenditure across developing countries, high growth offered by emerging markets), and challenges (lack of skilled professional) influencing the growth of diagnostic electrocardiogram (ECG) market
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the diagnostic electrocardiogram (ECG) market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the diagnostic electrocardiogram (ECG) market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the diagnostic electrocardiogram (ECG) market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Table of Contents

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS & EXCLUSIONS 23
1.3 STUDY SCOPE 24
FIGURE 1 MARKETS COVERED 24
1.3.1 GEOGRAPHIC SCOPE 24
1.3.2 YEARS CONSIDERED 25
1.4 CURRENCY CONSIDERED 25
1.5 KEY MARKET STAKEHOLDERS 25
1.6 SUMMARY OF CHANGES 26
1.7 RECESSION IMPACT ON DIAGNOSTIC ECG MARKET 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 2 RESEARCH DESIGN 27
2.1.1 SECONDARY DATA 28
2.1.2 PRIMARY RESEARCH 29
2.1.2.1 Key data from primary sources 29
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 30
FIGURE 4 DIAGNOSTIC ECG MARKET: BREAKDOWN OF PRIMARIES 30
2.2 MARKET SIZE ESTIMATION METHODOLOGY 30
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 31
2.2.1 PRODUCT-BASED MARKET ESTIMATION 31
2.2.2 END USER-BASED MARKET ESTIMATION 32
FIGURE 6 MARKET SIZE ESTIMATION: DIAGNOSTIC ECG MARKET 32
2.2.3 PRIMARY RESEARCH VALIDATION 33
2.3 DATA TRIANGULATION 34
FIGURE 7 DATA TRIANGULATION METHODOLOGY 34
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 35
2.4.1 RESEARCH ASSUMPTIONS 35
2.4.2 RESEARCH LIMITATIONS 35
2.5 RECESSION IMPACT 35
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 36
 
3 EXECUTIVE SUMMARY 37
FIGURE 8 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 37
FIGURE 9 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023 VS. 2028 (USD MILLION) 38
FIGURE 10 DIAGNOSTIC ECG MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 38
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC ECG MARKET 39
4 PREMIUM INSIGHTS 40
4.1 DIAGNOSTIC ECG MARKET OVERVIEW 40
FIGURE 12 INCREASING PREVALENCE OF CVD GLOBALLY TO DRIVE MARKET GROWTH 40
4.2 NORTH AMERICA: DIAGNOSTIC ECG MARKET SHARE, BY PRODUCT & COUNTRY (2022) 41
FIGURE 13 DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DIAGNOSTIC ECG MARKET IN 2022 41
4.3 DIAGNOSTIC ECG DEVICES MARKET SHARE, BY TYPE,  2023 VS. 2028 41
FIGURE 14 RESTING ECG DEVICES TO CAPTURE LARGEST SHARE OF DIAGNOSTIC ECG DEVICES MARKET IN 2022 41
4.4 DIAGNOSTIC ECG MARKET, BY LEAD TYPE,  2023 VS. 2028 (USD MILLION) 42
FIGURE 15 12-LEAD ECG DEVICES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 42
4.5 DIAGNOSTIC ECG MARKET, BY END USER,  2023 VS. 2028 (USD MILLION) 43
FIGURE 16 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT TO DOMINATE MARKET IN 2028 43
4.6 DIAGNOSTIC ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 44
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH IN DIAGNOSTIC ECG MARKET FROM 2023 TO 2028 44
5 MARKET OVERVIEW 45
5.1 INTRODUCTION 45
5.2 MARKET DYNAMICS 45
FIGURE 18 DIAGNOSTIC ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
5.2.1 DRIVERS 46
5.2.1.1 Increasing incidence of lifestyle and cardiovascular diseases 46
5.2.1.2 Rapidly expanding global geriatric population and subsequent surge in heart conditions 46
5.2.1.3 Development of wireless monitoring and wearable cardiac devices 47
5.2.1.4 Increasing investments, funds, and grants for research on cardiac diagnosis 47
5.2.2 RESTRAINTS 48
5.2.2.1 Stringent regulatory requirements delaying approval of  cardiac devices 48
5.2.3 OPPORTUNITIES 48
5.2.3.1 Emerging markets to offer high-growth opportunities 48
5.2.4 CHALLENGES 49
5.2.4.1 Dearth of skilled professionals 49
5.3 PRICING ANALYSIS 49
TABLE 2 AVERAGE SELLING PRICE OF DIAGNOSTIC ECG MONITORING PRODUCTS (2022) 49
5.4 PATENT ANALYSIS 50
FIGURE 19 PATENT ANALYSIS FOR DIAGNOSTIC ECG MARKET 50
5.5 VALUE CHAIN ANALYSIS 51
FIGURE 20 VALUE CHAIN ANALYSIS OF DIAGNOSTIC ECG MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 51
5.6 SUPPLY CHAIN ANALYSIS 52
FIGURE 21 DIAGNOSTIC ECG MARKET: SUPPLY CHAIN ANALYSIS 52
5.7 ECOSYSTEM ANALYSIS 53
FIGURE 22 DIAGNOSTIC ECG MARKET: ECOSYSTEM ANALYSIS 53
5.8 PORTER’S FIVE FORCES ANALYSIS 53
TABLE 3 DIAGNOSTIC ECG MARKET: PORTER’S FIVE FORCES ANALYSIS 53
5.8.1 THREAT OF NEW ENTRANTS 54
5.8.2 THREAT OF SUBSTITUTES 54
5.8.3 BARGAINING POWER OF BUYERS 54
5.8.4 BARGAINING POWER OF SUPPLIERS 54
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 54
5.9 REIMBURSEMENT SCENARIO 54
TABLE 4 CPT CODES FOR ECG PROCEDURES 55
5.10 REGULATORY ANALYSIS 55
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS 56
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS 56
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS 56
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS 57
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS 57
5.10.1 NORTH AMERICA 57
5.10.1.1 US 57
5.10.1.2 Canada 57
5.10.2 EUROPE 58
5.10.3 ASIA PACIFIC 58
5.10.3.1 China 58
5.10.3.2 Japan 58
5.10.3.3 India 58
5.10.4 LATIN AMERICA 59
5.10.4.1 Brazil 59
5.10.4.2 Mexico 59
5.10.5 MIDDLE EAST 59
5.10.6 AFRICA 60
5.11 TRADE ANALYSIS 60
5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC ECG PRODUCTS 60
TABLE 10 IMPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY,  2018–2022 (USD MILLION) 60
TABLE 11 EXPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY,  2018–2022 (USD MILLION) 61
5.12 TECHNOLOGY ANALYSIS 61
5.13 KEY CONFERENCES & EVENTS, 2023–2024 62
TABLE 12 DIAGNOSTIC ECG MARKET: DETAILED LIST OF CONFERENCES & EVENTS 62
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 63
5.14.1 REVENUE SHIFT AND REVENUE POCKETS FOR DIAGNOSTIC ECG MONITOR MANUFACTURERS 63
FIGURE 23 REVENUE SHIFT IN DIAGNOSTIC ECG MARKET 63
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 63
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 63
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS 63
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS 64
5.15.2 BUYING CRITERIA 64
FIGURE 25 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 64
TABLE 14 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS 64
6 DIAGNOSTIC ECG MARKET, BY PRODUCT 65
6.1 INTRODUCTION 66
TABLE 15 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 66
6.2 DEVICES 66
TABLE 16 DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 67
6.2.1 RESTING ECG DEVICES 67
6.2.1.1 Wide availability of resting ECG devices to support market growth 67
TABLE 17 RESTING ECG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 68
6.2.2 STRESS ECG DEVICES 68
6.2.2.1 High cost of stress ECG devices to limit adoption 68
TABLE 18 STRESS ECG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 69
6.2.3 HOLTER MONITORS 69
6.2.3.1 Growing demand for continuous monitoring to fuel growth 69
TABLE 19 HOLTER MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 70
6.2.4 EVENT MONITORS 70
6.2.4.1 Increasing outsourcing of monitoring devices to propel market growth 70
TABLE 20 EVENT MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 70
6.2.5 IMPLANTABLE LOOP RECORDERS 71
6.2.5.1 Introduction of technologically advanced implantable loop recorders to support market growth 71
TABLE 21 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 71
6.2.6 MOBILE CARDIAC TELEMETRY DEVICES 71
6.2.6.1 Increasing demand for cardiac monitoring solutions in home care settings to propel market 71
TABLE 22 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 72
6.2.7 SMART ECG MONITORS 72
6.2.7.1 Rising need to reduce treatment costs to drive adoption of smart/wearable ECG monitors 72
TABLE 23 SMART ECG MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 73
6.3 SOFTWARE & SERVICES 73
6.3.1 SHIFT TOWARDS AI-ENABLED ECG SOFTWARE TO SUPPORT GROWTH 73
TABLE 24 DIAGNOSTIC ECG SOFTWARE & SERVICES MARKET, BY REGION,  2021–2028 (USD MILLION) 74
7 DIAGNOSTIC ECG MARKET, BY LEAD TYPE 75
7.1 INTRODUCTION 76
TABLE 25 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028(USD MILLION) 76
7.2 12-LEAD ECG DEVICES 76
7.2.1 GROWING USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE MARKET GROWTH 76
TABLE 26 12-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 77
7.3 5-LEAD ECG DEVICES 77
7.3.1 GROWING IMPORTANCE OF PATIENT MONITORING TO BOOST ADOPTION 77
TABLE 27 5-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 77
7.4 3-LEAD ECG DEVICES 78
7.4.1 ABILITY TO MEET NEEDS OF MULTIPLE DIAGNOSTIC TESTS SIMULTANEOUSLY TO SUPPORT MARKET 78
TABLE 28 3-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 78
7.5 6-LEAD ECG DEVICES 78
7.5.1 GROWING USE OF 6-LEAD ECG DEVICES IN REMOTE PATIENT MONITORING TO FAVOR MARKET GROWTH 78
TABLE 29 6-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 79
7.6 SINGLE-LEAD ECG DEVICES 79
7.6.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO INCREASE USE OF SINGLE-LEAD ECG DEVICES 79
TABLE 30 SINGLE-LEAD ECG DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 79
7.7 OTHER ECG LEAD DEVICES 80
TABLE 31 OTHER ECG LEAD DEVICES MARKET, BY REGION, 2021–2028(USD MILLION) 80
 
8 DIAGNOSTIC ECG MARKET, BY END USER 81
8.1 INTRODUCTION 82
TABLE 32 DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 82
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS 82
8.2.1 INCREASING UTILIZATION OF ECG DEVICES IN HOSPITALS & CARDIAC CENTERS TO ACCELERATE MARKET GROWTH 82
TABLE 33 DIAGNOSTIC ECG MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS,  BY REGION, 2021–2028 (USD MILLION) 83
8.3 AMBULATORY SURGERY CENTERS 83
8.3.1 GROWING ADOPTION OF OUTPATIENT SURGERIES TO SUPPORT GROWTH 83
TABLE 34 DIAGNOSTIC ECG MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION,  2021–2028 (USD MILLION) 84
8.4 OTHER END USERS 84
TABLE 35 DIAGNOSTIC ECG MARKET FOR OTHER END USERS, BY REGION,  2021–2028 (USD MILLION) 85
9 DIAGNOSTIC ECG MARKET, BY REGION 86
9.1 INTRODUCTION 87
TABLE 36 DIAGNOSTIC ECG MARKET, BY REGION, 2021–2028 (USD MILLION) 87
9.2 NORTH AMERICA 88
FIGURE 26 NORTH AMERICA: DIAGNOSTIC ECG MARKET SNAPSHOT 88
TABLE 37 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 38 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 89
TABLE 39 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 90
TABLE 40 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 90
9.2.1 NORTH AMERICA: RECESSION IMPACT 90
9.2.2 US 91
9.2.2.1 Growing number of FDA approvals for ECG devices to support market growth 91
TABLE 41 US: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
9.2.3 CANADA 91
9.2.3.1 Growing focus of government and private organizations on providing funding for research to drive market growth 91
TABLE 42 CANADA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 92
9.3 EUROPE 92
TABLE 43 EUROPE: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 44 EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 45 EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 94
TABLE 46 EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 94
9.3.1 EUROPE: RECESSION IMPACT 94
9.3.2 GERMANY 95
9.3.2.1 Germany to dominate diagnostic ECG market in Europe during forecast period 95
TABLE 47 GERMANY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 95
9.3.3 FRANCE 95
9.3.3.1 Rising prevalence of heart failure to drive adoption of diagnostic ECG devices 95
TABLE 48 FRANCE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
9.3.4 UK 96
9.3.4.1 Rising demand for home-based smart ECG devices to support market growth. 96
TABLE 49 UK: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
9.3.5 ITALY 97
9.3.5.1 Rising incidence of heart diseases to increase use of diagnostic ECG devices 97
TABLE 50 ITALY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 98
9.3.6 SPAIN 98
9.3.6.1 Rising geriatric population to support market growth in Spain 98
TABLE 51 SPAIN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
9.3.7 REST OF EUROPE 99
TABLE 52 REST OF EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 99
9.4 ASIA PACIFIC 100
FIGURE 27 ASIA PACIFIC: DIAGNOSTIC ECG MARKET SNAPSHOT 101
TABLE 53 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 54 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
TABLE 55 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,  2021–2028 (USD MILLION) 103
TABLE 56 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 103
9.4.1 ASIA PACIFIC: RECESSION IMPACT 103
9.4.2 JAPAN 104
9.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan 104
TABLE 57 JAPAN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
9.4.3 CHINA 105
9.4.3.1 Government support for infrastructural improvement to drive market growth 105
TABLE 58 CHINA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
9.4.4 INDIA 106
9.4.4.1 Government initiatives to propel market growth 106
TABLE 59 INDIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
9.4.5 AUSTRALIA 107
9.4.5.1 Growing adoption of telemedicine and remote patient monitoring to boost market 107
TABLE 60 AUSTRALIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
9.4.6 SOUTH KOREA 108
9.4.6.1 Rising geriatric population to propel market growth 108
TABLE 61 SOUTH KOREA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
9.4.7 REST OF ASIA PACIFIC 109
TABLE 62 REST OF ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 109
9.5 LATIN AMERICA 109
TABLE 63 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 64 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 110
TABLE 65 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021–2028 (USD MILLION) 111
TABLE 66 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021–2028 (USD MILLION) 111
9.5.1 LATIN AMERICA: RECESSION IMPACT 111
9.5.2 BRAZIL 112
9.5.2.1 Improving access to diagnostic services to drive growth 112
TABLE 67 BRAZIL: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
9.5.3 MEXICO 113
9.5.3.1 Government support for infrastructural improvement to drive market growth 113
TABLE 68 MEXICO: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
9.5.4 REST OF LATIN AMERICA 113
TABLE 69 REST OF LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 114
9.6 MIDDLE EAST & AFRICA 114
9.6.1 GROWING MEDICAL COVERAGE IN REGION TO SUPPORT GROWTH 114
TABLE 70 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 115
TABLE 71 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE,  2021–2028 (USD MILLION) 115
TABLE 72 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER,  2021–2028 (USD MILLION) 116
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 116
10 COMPETITIVE LANDSCAPE 117
10.1 OVERVIEW 117
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 117
FIGURE 28 KEY DEVELOPMENTS IN DIAGNOSTIC ECG MARKET (2020–2023) 117
10.3 REVENUE SHARE ANALYSIS 118
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2019–2022) 118
10.4 MARKET SHARE ANALYSIS 119
FIGURE 30 DIAGNOSTIC ECG MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 119
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 119
10.5.1 STARS 119
10.5.2 PERVASIVE PLAYERS 119
10.5.3 EMERGING LEADERS 119
10.5.4 PARTICIPANTS 120
FIGURE 31 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 120
10.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 121
10.6.1 PROGRESSIVE COMPANIES 121
10.6.2 DYNAMIC COMPANIES 121
10.6.3 RESPONSIVE COMPANIES 121
10.6.4 STARTING BLOCKS 121
FIGURE 32 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 122
10.7 COMPETITIVE BENCHMARKING 123
10.7.1 OVERALL COMPANY FOOTPRINT 123
TABLE 73 OVERALL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET 123
10.7.2 COMPANY PRODUCT FOOTPRINT 123
TABLE 74 PRODUCT FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET 123
10.7.3 COMPANY REGIONAL FOOTPRINT 124
TABLE 75 REGIONAL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET 124
10.8 COMPETITIVE SCENARIO (2020–2023) 125
10.8.1 PRODUCT LAUNCHES & APPROVALS 125
TABLE 76 DIAGNOSTIC ECG MARKET: KEY PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–AUGUST 2023) 125
10.8.2 DEALS 126
TABLE 77 DIAGNOSTIC ECG MARKET: KEY DEALS (JANUARY 2020–AUGUST 2023) 126
10.8.3 OTHER DEVELOPMENTS 127
TABLE 78 DIAGNOSTIC ECG MARKET: OTHER DEVELOPMENTS (JANUARY 2020–AUGUST 2023) 127
11 COMPANY PROFILES 128
11.1 KEY PLAYERS 128
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 GE HEALTHCARE 128
TABLE 79 GE HEALTHCARE: COMPANY OVERVIEW 128
FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 129
11.1.2 KONINKLIJKE PHILIPS N.V. 132
TABLE 80 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 132
FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 133
11.1.3 HILL-ROM HOLDINGS, INC. (BAXTER INTERNATIONAL INC.) 136
TABLE 81 HILL-ROM HOLDINGS, INC.: COMPANY OVERVIEW 136
FIGURE 35 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2022) 137
11.1.4 FUKUDA DENSHI 140
TABLE 82 FUKUDA DENSHI: BUSINESS OVERVIEW 140
FIGURE 36 FUKUDA DENSHI: COMPANY SNAPSHOT (2022) 141
11.1.5 MINDRAY MEDICAL INTERNATIONAL LIMITED 143
TABLE 83 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 143
FIGURE 37 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2021) 144
11.1.6 NIHON KOHDEN CORPORATION 146
TABLE 84 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 146
FIGURE 38 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022) 147
11.1.7 OSI SYSTEMS, INC. 149
TABLE 85 OSI SYSTEMS, INC: BUSINESS OVERVIEW 149
FIGURE 39 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2022) 150
11.1.8 BPL MEDICAL TECHNOLOGIES 153
TABLE 86 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 153
11.1.9 SCHILLER AG 155
TABLE 87 SCHILLER AG: BUSINESS OVERVIEW 155
11.1.10 BITTIUM 157
TABLE 88 BITTIUM: BUSINESS OVERVIEW 157
FIGURE 40 BITTIUM: COMPANY SNAPSHOT (2022) 158
11.1.11 ACS DIAGNOSTICS 160
TABLE 89 ACS DIAGNOSTICS: BUSINESS OVERVIEW 160
11.1.12 ALLENGERS MEDICAL SYSTEMS LTD. 161
TABLE 90 ALLENGERS MEDICAL SYSTEMS LTD: BUSINESS OVERVIEW 161
11.1.13 BIONET 162
TABLE 91 BIONET: BUSINESS OVERVIEW 162
11.1.14 CARDIAC INSIGHT, INC. 163
TABLE 92 CARDIAC INSIGHT, INC.: BUSINESS OVERVIEW 163
11.1.15 BTL 164
TABLE 93 BTL: BUSINESS OVERVIEW 164
11.2 OTHER PLAYERS 165
11.2.1 MEDITECH EQUIPMENT CO. LTD. 165
11.2.2 MIDMARK CORPORATION 165
11.2.3 ALIVECOR, INC. 166
11.2.4 VITALCONNECT 166
11.2.5 IRHYTHM TECHNOLOGIES, INC. 167
11.2.6 BORSAM BIOMEDICAL INSTRUMENTS CO., LTD. 167
11.2.7 NASIFF ASSOCIATES, INC. 168
11.2.8 VECTRACOR 168
11.2.9 BIOMEDICAL INSTRUMENTS CO. LTD. 169
11.2.10 LIFESIGNALS, INC. 170
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 171
12.1 DISCUSSION GUIDE 171
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 174
12.3 CUSTOMIZATION OPTIONS 176
12.4 RELATED REPORTS 176
12.5 AUTHOR DETAILS 177